Riskpilot← Back to searchSign inGet full accessCEDERLINGS GULDSMEDSAFFÄR AB
ABActiveOrg 5566151881Hökartorget 1Retail sale of watches and jewellery · NACE 4777Est. 20012 employees
Revenue 2025
SEK 2,6M
-5% vs 2024
EBITDA margin
4.8%
-32% vs 2024
Equity ratio
46.0%
Financial strength
Net profit 2025
SEK 73K
-34% vs 2024
| Revenue | SEK 2,6M | -5% |
| EBITDA | SEK 126K | -32% |
| Net profit | SEK 73K | -34% |
| Total assets | SEK 798K | +10% |
| Equity | SEK 367K | -7% |
| Employees | 2 | — |
Legal name
CEDERLINGS GULDSMEDSAFFÄR AB
Org number
5566151881
Legal form
Aktiebolag
NACE code
4777 · Retail sale of watches and jewellery
Founded
4 september 2001
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att driva guldsmedsaffär med försäljning och reparation av guldsmedsvaror samt därmed förenlig verksamhet.
Address
Hökartorget 1
Phone
+46225711217
Email
cederlings@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 713 | 2 057 | 2 081 | 2 758 | 2 630 |
| Staff expenses | — | — | −917 | −984 | −1 040 |
| EBITDA | 44 | 157 | −38 | 185 | 126 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 44 | 157 | −38 | 185 | 126 |
| Net financials | −2 | −1 | −1 | 2 | 0 |
| Profit before tax | 41 | 112 | 18 | 140 | 93 |
| Tax | −13 | −28 | 7 | −29 | −20 |
| Net profit | 28 | 84 | 24 | 111 | 73 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 681 | 698 | 608 | 728 | 798 |
| Equity | 388 | 372 | 296 | 394 | 367 |
| Long-term debt | 76 | 89 | 134 | 38 | 50 |
| Short-term debt | 160 | 136 | 133 | 206 | 257 |
| Total debt | 236 | 225 | 267 | 244 | 307 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
46.0%
This company
38.2%
Market median
+20% vs market
20212025
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20212025
Asset turnover
3.30×
This company
1.12×
Market median
+195% vs market
20212025
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MH | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CEDERLINGS GULDSMEDSAFFÄR AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Helén Gunnarsson | Audit | 0 companies |
| Emma Veronica Eriksson | Board of Directors | 0 companies |
| Jan Anders Eriksson | Deputy Board Member | 0 companies |